The global poultry medicine/pharmaceuticals market was valued at USD 4.73 billion in 2023 and is anticipated to grow at a CAGR of 5.9% during the forecast period of 2024-2032, reaching USD 7.92 billion by 2032. The expansion of the market is largely driven by increased poultry consumption, population growth, technological advancements in disease prevention, and rising concerns regarding food safety and sustainability in poultry farming.
The surging demand for protein-rich foods, particularly poultry meat and eggs, has fueled the expansion of poultry farming, necessitating robust disease prevention and treatment solutions. Newcastle disease, Avian Influenza, and Coccidiosis remain key challenges in poultry farming, driving demand for effective vaccines, antibiotics, and immune boosters. The stringent regulations on antibiotic use in livestock have further accelerated the adoption of probiotics, vaccines, and alternative treatments, promoting sustainable poultry production.
Furthermore, advancements in in ovo vaccination technology have revolutionized large-scale immunization, reducing labor costs and enhancing disease control. The growth of industrial poultry farming in emerging markets, particularly in Asia-Pacific, Latin America, and Africa, has created substantial opportunities for pharmaceutical innovations tailored for large-scale poultry operations.
Growing Need for Disease Prevention to Drive Market Growth- The poultry industry faces substantial risks from highly contagious poultry diseases, prompting extensive vaccination programs to mitigate economic losses. Vaccines account for the largest market share due to their necessity in preventing Newcastle disease, Avian Influenza, and Infectious Bronchitis, which can devastate poultry farms and impact trade. The increasing regulatory restrictions on antibiotics in food production have further propelled the demand for alternative disease prevention methods, such as probiotics and immune boosters.
Recent innovations, such as thermostable and vector-based vaccines, offer improved efficacy, while the widespread adoption of oral administration methods ensures efficient mass treatment for large poultry populations. The shift toward precision medicine in poultry healthcare, coupled with government-mandated vaccination programs, is expected to drive continued market expansion.
Regional Market Insights- The Asia-Pacific region dominates the poultry medicine/pharmaceuticals market, driven by high poultry consumption, rapid urbanization, and increasing disposable incomes in countries like China, India, and Indonesia. The rise of commercial poultry farms and the prevalence of poultry diseases in the region have led to significant investments in preventive healthcare and vaccination strategies.
In North America and Europe, stringent regulatory policies on antibiotic usage and the adoption of sustainable farming practices have fueled the demand for probiotics and non-antibiotic alternatives. Meanwhile, Latin America and Africa present growth opportunities due to the increasing demand for affordable protein sources, leading to the expansion of poultry farming and disease management initiatives.
Key Poultry Medicine/Pharmaceutical Companies
• MSD Animal Health (US)
• Elanco Animal Health (US)
• Boehringer Ingelheim (Germany)
• Ceva Santé Animale (France)
• Zoetis Services LLC (US)
• Virbac (France)
• Phibro Animal Health (US)
• HIPRA (Spain)
• Vetoquinol (France)
• Biovet (Bulgaria)
• Huvepharma (Bulgaria)
• Indian Immunologicals Ltd (India)
• Anicon GmbH (Germany)
• IDEXX Laboratories (US)
• Kemin Industries (US)
The Detailed Segments and Sub-segments of the Market are Explained Below:
By Product:
• Vaccines
Live Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
• Antibiotics
Tetracyclines
Macrolides
Beta-lactams
Sulfonamides
• Probiotics & Prebiotics
• Immune Boosters & Growth Enhancers
• Parasiticides
• Other Pharmaceuticals
By Disease Indication:
• Newcastle Disease
• Avian Influenza
• Infectious Bronchitis
• Coccidiosis
• Fowl Cholera
• Marek’s Disease
• Other Poultry Diseases
By Route of Administration:
• Oral (Feed & Water)
• Injectable
• Topical
• Other Routes
By Animal Type:
• Chickens
• Turkeys
• Ducks
• Other Poultry
By Region:
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Netherlands
Asia-Pacific
• China
• India
• Japan
• Indonesia
• Australia
• South Korea
Latin America
• Brazil
• Argentina
• Mexico
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years (2022-2032).
• Annualized revenue and regional-level analysis for each market segment.
• Detailed geographical landscape with country-level analysis of major regions.
• Competitive landscape with market share insights from leading players.
• Analysis of key business strategies and recommendations for future market positioning.
• Competitive structure evaluation with SWOT analysis of major companies.
• Demand-side and supply-side assessment of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- Chapter 1. Global Primary Cell Culture Market Executive Summary
- 1.1. Global Primary Cell Culture Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Cell Type
- 1.3.3. By Application
- 1.3.4. By End-use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Primary Cell Culture Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Primary Cell Culture Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rising Demand for Biologics and Personalized Medicine
- 3.1.2. Expansion of Cell & Gene Therapy Research
- 3.1.3. Increasing R&D Investment in Pharmaceutical & Biotechnology Companies
- 3.2. Market Challenges
- 3.2.1. High Costs Associated with Primary Cell Culture Research
- 3.2.2. Ethical Concerns and Stringent Regulatory Guidelines
- 3.3. Market Opportunities
- 3.3.1. Advancements in 3D Cell Culture and Organoid Models
- 3.3.2. Growing Outsourcing Trends Among Pharmaceutical & Biotech Companies
- 3.3.3. Expanding Applications in Vaccine Development and Toxicology Studies
- Chapter 4. Global Primary Cell Culture Market Industry Analysis
- 4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
- 4.1.7. Porter’s 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Primary Cell Culture Market Size & Forecasts by Product (2022-2032)
- 5.1. Segment Dashboard
- 5.2. Global Primary Cell Culture Market: Product Revenue Trend Analysis (2022 & 2032)
- 5.2.1. Primary Cells
- • Hematopoietic Cells
- • Skin Cells
- • Hepatocytes
- • Gastrointestinal Cells
- • Lung Cells
- • Renal Cells
- • Heart Cells
- • Skeletal and Muscle Cells
- • Other Primary Cells
- 5.2.2. Media
- • Serum-free Media
- • Serum-containing Media
- • Others
- 5.2.3. Reagents and Supplements
- • Attachment Solutions
- • Buffers and Salts
- • Freezing Media
- • Sera
- • Growth Factors and Cytokines
- • Others
- Chapter 6. Global Primary Cell Culture Market Size & Forecasts by Cell Type (2022-2032)
- 6.1. Segment Dashboard
- 6.2. Global Primary Cell Culture Market: Cell Type Revenue Trend Analysis (2022 & 2032)
- 6.2.1. Human Cells
- 6.2.2. Animal Cells
- Chapter 7. Global Primary Cell Culture Market Size & Forecasts by Application (2022-2032)
- 7.1. Segment Dashboard
- 7.2. Global Primary Cell Culture Market: Application Revenue Trend Analysis (2022 & 2032)
- 7.2.1. Cell & Gene Therapy Development
- 7.2.2. Vaccine Production
- 7.2.3. Model System
- 7.2.4. Virology
- 7.2.5. Prenatal Diagnosis
- 7.2.6. Others
- Chapter 8. Global Primary Cell Culture Market Size & Forecasts by End-use (2022-2032)
- 8.1. Segment Dashboard
- 8.2. Global Primary Cell Culture Market: End-use Revenue Trend Analysis (2022 & 2032)
- 8.2.1. Pharmaceutical & Biotechnology Companies
- 8.2.2. CMOs & CROs
- 8.2.3. Academic Research Institutes
- Chapter 9. Global Primary Cell Culture Market Size & Forecasts by Region (2022-2032)
- 9.1. North America Primary Cell Culture Market
- 9.1.1. U.S. Primary Cell Culture Market
- 9.1.1.1. Product breakdown size & forecasts (2022-2032)
- 9.1.1.2. Cell Type breakdown size & forecasts (2022-2032)
- 9.1.1.3. Application breakdown size & forecasts (2022-2032)
- 9.1.2. Canada Primary Cell Culture Market
- 9.1.3. Mexico Primary Cell Culture Market
- 9.2. Europe Primary Cell Culture Market
- 9.2.1. UK Primary Cell Culture Market
- 9.2.2. Germany Primary Cell Culture Market
- 9.2.3. France Primary Cell Culture Market
- 9.2.4. Italy Primary Cell Culture Market
- 9.2.5. Spain Primary Cell Culture Market
- 9.2.6. Denmark Primary Cell Culture Market
- 9.2.7. Sweden Primary Cell Culture Market
- 9.2.8. Norway Primary Cell Culture Market
- 9.3. Asia-Pacific Primary Cell Culture Market
- 9.3.1. Japan Primary Cell Culture Market
- 9.3.2. China Primary Cell Culture Market
- 9.3.3. India Primary Cell Culture Market
- 9.3.4. Australia Primary Cell Culture Market
- 9.3.5. Thailand Primary Cell Culture Market
- 9.3.6. South Korea Primary Cell Culture Market
- 9.4. Latin America Primary Cell Culture Market
- 9.4.1. Brazil Primary Cell Culture Market
- 9.4.2. Argentina Primary Cell Culture Market
- 9.5. Middle East & Africa Primary Cell Culture Market
- 9.5.1. South Africa Primary Cell Culture Market
- 9.5.2. Saudi Arabia Primary Cell Culture Market
- 9.5.3. UAE Primary Cell Culture Market
- 9.5.4. Kuwait Primary Cell Culture Market
- Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. Thermo Fisher Scientific Inc.
- 10.1.2. Merck KGaA
- 10.1.3. Lonza
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- 10.3.1. Thermo Fisher Scientific Inc.
- 10.3.2. Merck KGaA
- 10.3.3. Lonza
- 10.3.4. STEMCELL Technologies
- 10.3.5. Cell Biologics, Inc.
- 10.3.6. PromoCell
- 10.3.7. ZenBio
- 10.3.8. AllCells
- 10.3.9. American Type Culture Collection
- 10.3.10. Axol Biosciences Ltd.
- Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- List of Tables
- TABLE 1. Global Primary Cell Culture market, report scope
- TABLE 2. Global Primary Cell Culture market estimates & forecasts by Region 2022-2032 (USD Million/Billion)
- TABLE 3. Global Primary Cell Culture market estimates & forecasts by Product 2022-2032 (USD Million/Billion)
- TABLE 4. Global Primary Cell Culture market estimates & forecasts by Cell Type 2022-2032 (USD Million/Billion)
- TABLE 5. Global Primary Cell Culture market estimates & forecasts by Application 2022-2032 (USD Million/Billion)
- TABLE 6. Global Primary Cell Culture market estimates & forecasts by End Use 2022-2032 (USD Million/Billion)
- TABLE 7. Global Primary Cell Culture market by segment, estimates & forecasts, 2022-2032 (USD Million/Billion)
- TABLE 8. Global Primary Cell Culture market by region, estimates & forecasts, 2022-2032 (USD Million/Billion)
- ...
- (This list is not complete. The final report contains more than 100 tables. The list may be updated in the final deliverable.)
- List of Figures
- FIGURE 1. Global Primary Cell Culture market, research methodology
- FIGURE 2. Global Primary Cell Culture market, market estimation techniques
- FIGURE 3. Global market size estimates & forecast methods.
- FIGURE 4. Global Primary Cell Culture market, key trends 2023
- FIGURE 5. Global Primary Cell Culture market, growth prospects 2022-2032
- FIGURE 6. Global Primary Cell Culture market, porters 5 force model
- FIGURE 7. Global Primary Cell Culture market, PESTEL analysis
- FIGURE 8. Global Primary Cell Culture market, value chain analysis
- FIGURE 9. Global Primary Cell Culture market by segment, 2022 & 2032 (USD Million/Billion)
- FIGURE 10. North America Primary Cell Culture market 2022 & 2032 (USD Million/Billion)
- FIGURE 11. Europe Primary Cell Culture market 2022 & 2032 (USD Million/Billion)
- FIGURE 12. Asia-Pacific Primary Cell Culture market 2022 & 2032 (USD Million/Billion)
- FIGURE 13. Global Primary Cell Culture market, company market share analysis (2023)
- ...
- (This list is not complete. The final report contains more than 50 figures. The list may be updated in the final deliverable.)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook